NCT01467999View on ClinicalTrials.gov

Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

October 31, 2016

Conditions
Cannabis Dependence
Interventions
DRUG

Guanfacine

Guanfacine, 4mg given once daily

Trial Locations (1)

10032

STARS, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT01467999 - Open-Label Pilot Study of Guanfacine-Extended Release for the Treatment of Cannabis Dependence | Biotech Hunter | Biotech Hunter